Newsletter

McDermott International Awarded Contract from Naftna Industrija Srbije (NIS)

McDermott International, Inc. (MDR) announced on December 17 that the company received a sizeable technology contract award from Naftna Industrija Srbije (NIS). Under the terms of the contract, McDermott will provide engineering services in order to modernize the existing Fluid Catalytic Cracking (FCC) unit. The work will assist in the production of bio ethanol base Ethyl […]

0Comments

FDA Approves Caplyta by Intra-Cellular Therapies to Treat Schizophrenia

On December 23, Intra-Cellular Therapies, Inc. (ITCI) announced that it received FDA approval of drug CAPLYTA®(lumateperone) for the treatment of schizophrenia in adults. Schizophrenia is a serious mental illness impacting approximately 2.4 million adults in the United States. The company expects to launch CAPLYTA® by the end of the first quarter in 2020.   Jet […]

0Comments

Leidos Awarded $6.5 Billion Defense Contract

On December 12, Leidos (LDOS) announced it received a contract award from the Defense Information Systems Agency (DISA). The contract has a give-year base period of performance with another three-year of options and is worth $6.5 billion. Leidos will operate, defend, and sustain the Department of Defense network used by more than 3,000 sites around […]

0Comments

McDermott International Contracts with New Wave Energy on Project Traveler

McDermott International, Inc. (MDR) announced on December 12 that the company received a sizeable contract award. Under the terms of the contract, McDermott will share its proprietary Dimer® process with Next Wave Energy Partners. Next Wave Energy’s grassroots alkylate production facility, known as Project Traveler, will use McDermott’s unique ethylene dimerization process.   Jet Equities […]

0Comments

Antero Midstream Announces Share Repurchase and New Growth Incentives for Antero Resources

Antero Midstream Corporation (AM) announced on December 9 that the company agreed to repurchase $100 million of common shares from Antero Resources Corporation. In addition, Antero Midstream agreed to provide a reduction in low pressure gathering fees for volumes gathered from January 1, 2020 through December 31, 2023 subject to achieving set volume targets. The […]

0Comments

Canadian Solar Announces $150 Million Share Repurchase Program

On December 9, Canadian Solar, Inc. (CSIQ) announced that its Board of Directors authorized a new share repurchase programs. Under the terms of the program, Canadian Solar may repurchase up to $150 million in common shares through June 8, 2020. Canadian Solar is one of the world’s largest solar power companies.   Jet Equites issued […]

0Comments

FDA Approves Oxbryta™ (voxelotor) for Sickle Cell Disease

Global Blood Therapeutics (GBT), the maker of Oxbryta™ (voxelotor), announced on November 25 that the FDA granted accelerated approval for the treatment of sickle cell disease. The drug is a once daily tablet for adults and children 12 years of age and older. It is the first approved treatment that directly inhibits sickle hemoglobin polymerization, […]

0Comments

Burlington Beats Third Quarter Estimates and Increases Annual EPS Guidance

On November 26, Burlington Stores, Inc. (BURL) reported that third quarter earnings beat expectations. Total sales increased 8.6% over the previous year, and EPS increased 29% to $1.44 per share. As a result, Burlington increased its annual earnings guidance from between $7.14 and $7.22 per share to between $7.28 and $7.33 per share.    Jet […]

0Comments

Fluent’s Board of Directors Approves Share Repurchase Program

On November 19, Fluent, Inc. (FLNT) announced that the company’s Board of Directors approved a new share repurchase program. Under the terms of the program, the company can repurchase up to $5 million in outstanding common shares. Fluent is a leading data-driven performance marketing company.   Jet Equities alerted subscribers about the news event at […]

0Comments